Modern Diagnostic & Research Centre Ltd
Incorporated in 1985, Modern Diagnostic & Research Centre Limited (MDRC) is a diagnostic chain in India, offering a comprehensive range of pathology and radiology services.[1]
- Market Cap ₹ 112 Cr.
- Current Price ₹ 74.0
- High / Low ₹ 100 / 45.0
- Stock P/E 21.3
- Book Value ₹ 38.8
- Dividend Yield 0.00 %
- ROCE 12.5 %
- ROE 13.2 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 31.0%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Part of BSE SME IPO
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 60.21 | 56.28 | 67.13 | 77.95 | 83.11 | |
| 54.19 | 57.26 | 55.99 | 59.84 | 70.30 | |
| Operating Profit | 6.02 | -0.98 | 11.14 | 18.11 | 12.81 |
| OPM % | 10.00% | -1.74% | 16.59% | 23.23% | 15.41% |
| 0.35 | 0.32 | 1.46 | 0.86 | 1.03 | |
| Interest | 1.57 | 1.41 | 1.81 | 1.91 | 2.66 |
| Depreciation | 3.66 | 3.87 | 3.92 | 4.19 | 5.19 |
| Profit before tax | 1.14 | -5.94 | 6.87 | 12.87 | 5.99 |
| Tax % | 227.19% | -3.54% | 15.57% | 29.99% | 12.19% |
| -1.45 | -5.73 | 5.79 | 9.01 | 5.25 | |
| EPS in Rs | -14.50 | -57.30 | 57.90 | 8.19 | 3.48 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 14% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 43% |
| TTM: | -42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 31% |
| Last Year: | 13% |
Balance Sheet
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 1.00 | 1.00 | 1.00 | 11.00 | 15.10 |
| Reserves | 10.70 | 4.96 | 10.76 | 9.77 | 43.45 |
| 20.40 | 15.31 | 20.46 | 22.09 | 37.10 | |
| 16.60 | 15.27 | 17.26 | 21.71 | 22.95 | |
| Total Liabilities | 48.70 | 36.54 | 49.48 | 64.57 | 118.60 |
| 24.31 | 23.67 | 27.04 | 30.65 | 48.09 | |
| CWIP | 0.75 | 0.00 | 3.60 | 9.11 | 10.18 |
| Investments | 5.29 | 0.11 | 0.21 | 0.23 | 16.97 |
| 18.35 | 12.76 | 18.63 | 24.58 | 43.36 | |
| Total Assets | 48.70 | 36.54 | 49.48 | 64.57 | 118.60 |
Cash Flows
Figures in Rs. Crores
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 3.64 | -0.12 | 7.93 | 13.90 | 3.82 | |
| -5.20 | 2.11 | -11.03 | -13.31 | -40.29 | |
| 4.50 | -6.47 | 3.36 | -0.22 | 45.08 | |
| Net Cash Flow | 2.94 | -4.48 | 0.26 | 0.37 | 8.62 |
| Free Cash Flow | -1.49 | -3.27 | -3.04 | 0.58 | -19.88 |
| CFO/OP | 52% | 12% | 60% | 98% | 36% |
Ratios
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 54.56 | 52.27 | 56.28 | 59.75 | 69.30 |
| Inventory Days | 25.90 | 40.62 | 61.45 | 95.47 | 119.58 |
| Days Payable | 172.38 | 170.83 | 177.12 | 160.28 | 196.43 |
| Cash Conversion Cycle | -91.92 | -77.94 | -59.39 | -5.06 | -7.55 |
| Working Capital Days | -43.95 | -58.82 | -34.74 | -37.79 | -41.68 |
| ROCE % | -17.24% | 32.75% | 39.37% | 12.48% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| B2B Revenue Mix % |
|
||
| Haryana Revenue Share (Domestic) % |
|||
| Number of Patients Served Unit |
|||
| Number of Tests Unit |
|||
| Pathology Revenue Mix % |
|||
| Tests per Patient Tests/Patient |
|||
Extracted by Screener AI
Documents
Announcements
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
- 14th AGM held on 30 Sep 2026; members approved financials, director reappointment, and auditor reappointment.
-
Closure of Trading Window
- Trading window closed from 1 October 2026 until 48 hours after half-year results submission.
-
Clarification On Significant Movement In The Price Of The Securities Of The Company
- On 15 Sep 2026, company said no UPSI or undisclosed event explains recent price movement.
-
Clarification sought from Modern Diagnostic & Research Centre Ltd
- Exchange has sought clarification from Modern Diagnostic & Research Centre Ltd on September 15, 2026, with reference to Movement in Price.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Submission of newspaper publication, in which notice of 14th AGM, e-voting information and confirmation of dispatch of notice of 14th AGM has published
Business Profile[1]
Modern Diagnostic & Research Centre Limited is an integrated diagnostic services provider offering pathology and radiology services across India. The company operates a one-stop diagnostic model covering routine, high-end, and specialized tests for patients, hospitals, corporates, and healthcare providers.